Abbott (NYSE: ABT) reported Q1 EPS of $1.45, $0.10 better than the analyst estimate of $1.35. Revenue for the quarter came in at $10.7 billion versus the consensus estimate of $9.94 billion.

GUIDANCE:

Abbott sees 2021 EPS of at least $5.00, versus the consensus of $4.37.

• Abbott projects full-year 2021 diluted earnings per share from continuing operations under GAAP of at least $3.74. Abbott forecasts specified items for the full-year 2021 of $1.26 primarily related to intangible amortization, expenses associated with acquisitions, restructuring and cost reduction initiatives and other net expenses. Excluding specified items, projected adjusted diluted earnings per share from continuing operations would be at least $5.00 for full-year 2021.

For earnings history and earnings-related data on Abbott (ABT) click here.